BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16978874)

  • 1. Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands.
    Arenzana-Seisdedos F; Parmentier M
    Semin Immunol; 2006 Dec; 18(6):387-403. PubMed ID: 16978874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection.
    Shao W; Tang J; Song W; Wang C; Li Y; Wilson CM; Kaslow RA
    Genes Immun; 2007 Apr; 8(3):224-31. PubMed ID: 17330138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to HIV/AIDS: an individual characteristic we can measure?
    Jülg B; Goebel FD
    Infection; 2005 Jun; 33(3):160-2. PubMed ID: 15940420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymorphism of human alleles associated with genetic resistance against HIV-1 infection and its implications].
    Wang F; Liu D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):285-7. PubMed ID: 10932017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
    Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
    J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetic basis of HIV-1 infection, transmission and disease progression.
    Singh P; Kaur G; Sharma G; Mehra NK
    Vaccine; 2008 Jun; 26(24):2966-80. PubMed ID: 18321617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.
    Easterbrook PJ; Rostron T; Ives N; Troop M; Gazzard BG; Rowland-Jones SL
    J Infect Dis; 1999 Oct; 180(4):1096-105. PubMed ID: 10479136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic basis of HIV-1 resistance and susceptibility: an approach to understand correlation between human genes and HIV-1 infection.
    Kumar V; Prakash O; Manpreet S; Sumedh G; Medhi B
    Indian J Exp Biol; 2006 Sep; 44(9):683-92. PubMed ID: 16999022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5.
    Nakajima T; Kaur G; Mehra N; Kimura A
    Cytogenet Genome Res; 2008; 123(1-4):156-60. PubMed ID: 19287150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
    Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T
    J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
    Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
    J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
    Gonzalez E; Kulkarni H; Bolivar H; Mangano A; Sanchez R; Catano G; Nibbs RJ; Freedman BI; Quinones MP; Bamshad MJ; Murthy KK; Rovin BH; Bradley W; Clark RA; Anderson SA; O'connell RJ; Agan BK; Ahuja SS; Bologna R; Sen L; Dolan MJ; Ahuja SK
    Science; 2005 Mar; 307(5714):1434-40. PubMed ID: 15637236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of new variants within the two functional genes CCL3 and CCL3L encoding the CCL3 (MIP-1alpha) chemokine: implications for HIV-1 infection.
    Paximadis M; Mohanlal N; Gray GE; Kuhn L; Tiemessen CT
    Int J Immunogenet; 2009 Feb; 36(1):21-32. PubMed ID: 19055602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic determinant factors of resistance to HIV infection and of control of progression to AIDS: implications on pathogenesis and therapeutic approaches for the eradication of HIV. A review].
    Zúñiga J; Vargas-Alarcón G; Salgado N; Flores C; Martínez-Tripp S; Miranda A; Balbuena A; Osnaya N; Juárez F; Granados J; Reyes-Terán G
    Rev Invest Clin; 2000; 52(3):284-95. PubMed ID: 10953612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
    Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy.
    Guerini FR; Delbue S; Zanzottera M; Agliardi C; Saresella M; Mancuso R; Maserati R; Marchioni E; Gori A; Ferrante P
    Biomed Pharmacother; 2008 Jan; 62(1):26-30. PubMed ID: 17560067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemokines and immunomodulation: applications for HIV infections].
    Théodorou I; Combadière C; Faure S; Debré P
    J Soc Biol; 2002; 196(1):7-11. PubMed ID: 12134637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.